A patient is a candidate for an oral anticancer agent but has no prescription coverage. Why is this a disadvantage for the patient?
a) This may delay treatment
b) The provider will have to prescribe a lower dose to make it more affordable
c) The regimen will need to be changed to IV
d) There are no financial support services for PO drugs